adapted from Table 31-2: Way, W.L.,
Fields, H.L. and Way, E. L. Opioid Analgesics and
Antagonists, in Basic and
Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, p.
501; selection of an appropriate analgesic will
depend on the severity and type of pain.
Characterized by: reduced response to carbon dioxide challenge
Respiratory depression:
Dose-related
Influenced by
extent of sensory input
Opioid induced
--slight respiratory depression:
tolerated in patients with no prior
respiratory difficulty
Opioid induced -- slight
respiratory depression: poorly or not
tolerated in patients with:
Asthma
Chronic
obstructive pulmonary disease (COPD)
Cor pulmonale (right ventricular
hypertrophy secondary to pulmonary pathology or
pulmonary vascular pathology)
Increased
intracranial pressure
Nausea and vomiting
Increased intracranial pressure
With respiratory depression
(secondary to opioid administration), PCO2 increases and is
associated with:
Cerebral vasodilation (decrease in
cerebral vascular resistance)
Increase in cerebral blood flow
Increase in intracranial pressure
Hypotensive states --
worsened by preexisting hypovolemia or by
other medications given concurrently (e.g. nitroglycerin in
acute management of myocardial
infarction)
Constipation
Urinary retention
Urticaria, itching
adapted
from Table 31-5: Way, W.L., Fields, H.L.
and Way, E. L. Opioid Analgesics and
Antagonists, in Basic
and Clinical Pharmacology, (Katzung, B. G., ed)
Appleton-Lange